Clinical trials with GLP-1 receptor agonists consistently demonstrate significant weight loss, with higher doses (such as semaglutide 2.4 mg weekly) producing approximately 15% average weight loss in adults without diabetes in clinical trials (somewhat less in type 2 diabetes) when combined with lifestyle modification
The study of succinate as an oncometabolite has only recently begun, and more research needs to be conducted to completely understand its tumorigenic properties
Further large-scale, longitudinal studies are needed to clarify its clinical utility and mechanistic pathways in mood disorders
Avoid exceeding labelled directions unless instructed by a healthcare provider
Clinical evidence shows that topical glutathione reduces hyperpigmentation, leading to significant melanin reduction in conditions such as melasma
Matrixyl is gentle and non irritating, suitable for sensitive skin or people who are using anti-aging products for the first time